• 한국식품과학회지
• /
• 제43권6호
• /
• pp.675-682
• /
• 2011

본 연구는 국내/수입 유통되는 식품과 건강기능식품의 발기부전치료제 및 그 유사물질 혼입 농도를 모니터링하고, 그 결과를 바탕으로 식품의 안전성을 확보하고자 하였다. 전국에서 유통중인 식품 및 건강기능식품 총 226건을 구입하고 24종의 발기부전치료제 및 그 유사물질을 HPLC/PDA 및 LC-ESI-MS-MS를 이용하여 분석하였다. 고체 및 액체 시료의 전처리는 메탄올을 이용하여 추출하였다. 식품 및 건강기능식품 시료에서 확립된 시험법을 이용하여 식품과 건강기능식품 226건을 수거하여 모니터링한 결과, 5건의 성기능 표방 제품에서 acethylvardenafil, sildenafil, tadalafil이 검출되었다. 분석 결과, 검출량은 acethylvardenafil이 1종에서 21,476 mg/kg(15 mg/capsule)이었으며, sildenafil이 2종에서 각각 52,778 mg/kg(29 mg/capsule), 71,535 mg/kg (48 mg/capsule)이었고, tadalafil이 4종에서 9,772 mg/kg(6 mg/capsule) -55,545 mg/kg (33 mg/capsule)이었다. 따라서 식품 및 건강기능식품 중의 발기부전치료제 및 그 유사물질에 대한 지속적인 실태조사가 요구된다.

• 한국식품과학회지
• /
• 제43권5호
• /
• pp.558-563
• /
• 2011

복분자 와인은 복분자 열매를 발효 숙성시켜 제조한 것으로, 소비자에게 널리 음용되고 있으나 그 원재료인 복분자 열매에 대한 연구에 비해 복분자 와인에 존재하는 성분들에 대한 체계적인 연구는 거의 전무한 실정이다. 최근 우리는 복분자주에 함유되어 있는 화합물들의 분자 수준에서의 연구를 통하여 4-hydroxybenzoic acid, 3,4-dihydroxybenzoic acid, 4-(2-hydroxyethyl)-phenol, pyrocatechol, ethyl gallate 등의 5종의 저분자 페놀성 화합물을 단리 구조해석하여 보고한 바 있다. 그 연속된 연구로써 본 논문에서는 복분자주에 존재하는 성분들에 대한 추가적인 분리 및 구조해석을 행하였다. 제조된 복분자 와인(11 L, 복분자 열매 15.7 kg)을 용매분획하여 얻어진 EtOAc층(56.2 g)의 일부(20 g)를 silica gel column chromatography와 ODS-HPLC로 정제하여 5종의 화합물을 단리하였다. 이 화합물들을 대상으로 MS 및 NMR 등의 기기분석을 행한 결과, ethyl succinate(1, 13.1 mg), vanillic acid(2, 2.6 mg), ethyl 3,4-dihydroxybenzoate(3, 13. 1 mg), furan-2-ol(4, 1.3 mg), 그리고 4-(4-hydroxyphenyl) butan-2(S)-ol(5, 1.1 mg)로 동정하였다. 이 화합물들 대부분은 발효식품에서 향기성분으로 동정된 바 있으며, 화합물 2는 복분자 열매에 존재함이 이미 보고되어 있으나, 화합물 1과 3-5는 복분자 열매 및 복분자와인으로부터 처음으로 동정되었다.

• 분석과학
• /
• 제32권2호
• /
• pp.35-47
• /
• 2019

In this study, high-performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) was employed to detect 26 antidiabetic compounds in adulterated dietary supplements using a simple, selective method. The work presented herein may help prevent incidents related to food adulteration and restrict the illegal food market. The best separation was obtained on a Shiseido Capcell Pak(R) C18 MG-II ($2.0mm{\times}100mm$, $3{\mu}m$), which improved the peak shape and MS detection sensitivity of the target compounds. A gradient elution system composed of 0.1 % (v/v) formic acid in distilled water and methanol at a flow rate of 0.3 mL/min for 18 min was utilized. A triple quadrupole mass spectrometer with an electrospray ionization source operated in the positive or negative mode was employed as the detector. The developed method was validated as follows: specificity was confirmed in the multiple reaction monitoring mode using the precursor and product ion pairs. For solid samples, LOD ranged from 0.16 to 20.00 ng/mL and LOQ ranged from 0.50 to 60.00 ng/mL, and for liquid samples, LOD ranged from 0.16 to 20.00 ng/mL and LOQ ranged from 0.50 to 60.00 ng/mL. Satisfactory linearity was obtained from calibration curves, with $R^2$ > 0.99. Both intra and inter-day precision were less than 13.19 %. Accuracies ranged from 80.69 to 118.81 % (intra/inter-day), with a stability of less than 14.88 %. Mean recovery was found to be 80.6-119.0 % and less than 13.4 % RSD. Using the validated method, glibenclamide and pioglitazone were simultaneously determined in one capsule at concentrations of 1.52 and 0.53 mg (per capsule), respectively.

• 한국식품위생안전성학회지
• /
• 제34권1호
• /
• pp.65-72
• /
• 2019

본 연구에서는 곡류 및 견과 종실류 중 천연유래 보존료의 함유량을 조사하기 위하여 안식향산, 소브산 및 프로피온산의 함유량을 분석하였다. 곡류 및 견과 종실류 중 보존료 분석을 위하여 분석법을 확립하였다. 보존료 분석을 위하여 안식향산 및 소브산은 HPLC-DAD를 이용하여 정성 및 정량 분석 하였고 LC-MS/MS를 이용해 확인 분석하였다. 프로피온산은 GC-FID를 이용하여 정성 및 정량 분석 하였고 GC-MS를 이용해 확인 분석하였다. 보존료 분석법의 유효성을 검증하기 위해서 직선성, 회수율, LOD, LOQ를 검토한 결과, 모든 항목에서 양호한 결과를 나타내었다. 대상 시료는 곡류(백미, 보리, 밀 등) 275건, 견과 종실류(땅콩, 참깨, 커피원두 등) 427건을 수거하여 총 702건이었다. 함유량 조사 결과 안식향산은 대상시료 702건 중 44건의 시료에서 검출되었으며, 검출범위는 ND-23.74 mg/kg의 범위로 검출되었다. 소브산은 대상시료 702건 중 22건의 시료에서 검출되었고, 검출범위는 ND-7.90 mg/kg의 범위로 검출되었다. 프로피온산은 대상시료 702건 중 550건의 시료에서 검출되었으며, 검출범위는 ND-37.39 mg/kg의 범위로 검출되었다. 안식향산, 소브산, 프로피온산이 가장 높게 검출된 품목은 각각 참깨(23.74 mg/kg), 해바라기씨(7.90 mg/kg), 커피원두(37.39 mg/kg)이었다. 본 연구의 결과를 통해 곡류 및 견과 종실류 중 안식향산, 소브산, 프로피온산 분석법을 확립하였고 함유량조사 결과는 향후 식품 검사 시 보존료 사용기준 위반 판정으로 인한 민원제기나 국가 간 무역마찰 시 기초자료로 활용될 수 있을 것이다.

• 한국환경보건학회지
• /
• 제34권4호
• /
• pp.271-278
• /
• 2008

Dialkylated phthalates have been commonly used as plasticizers and a variety of applications. Phthalate diesters have been shown to be developmental and reproductive toxicants. It is very difficult to exactly estimate the dose of dialkylated phthalates taken up by the general population because of environmental contamination. Urinary metabolites of phthalates enabled to estimate internal exposure. The objective of this study was quantitative determination of phthalate metabolites by LC/MS/MS with on-line cleanup method to analyze phthalate metabolites in Korean children's urine. We employed LC/MS/MS with on-line enrichment and column-switching techniques for this biological monitoring. Metabolites determined were 4 primary metabolites; MEHP, MnBP, MiBP, MEP and 2 secondary metabolites of DEHP; 5-OH-MEHP), 5-oxo-MEHP. We analyzed children's urine from 30 boys and 30 girls. The method detection limit of phthalate metabolites were 0.03 ng/mL for MEP, 1.05 ng/mL for MBP, 0.22 ng/mL for MEHP, 0.15 ng/mL for 5-OHMEHP and 0.16 ng/mL for 5-oxo-MEHP, respectively. Switching Column LC/MS/MS was proven to be a useful tool to determine metabolites of phthalate diesters in human urine. The correlation among phthalate metabolites was very high and statistically significant, except MEP. The children's age (months) was negatively correlated to the concentration of phthalate metabolites. The geometric mean concentration of phthalate metabolites (mg/g creatinine) in children's urine were 25.5 for MEP, 130.3 for MnBP, 56.8 for MiBP, 19.5 for MEHP, 85.6 for 5-OH-MEHP and 83.1 for 5-oxo-MEHP, respectively. Levels of estimated daily intake of parent phthalate compounds (${\mu}g$/kg bw/day) were 0.8 for DEP, 5.0 for DnBP, 1.9 for DiBP and $8.9{\sim}14.2$ for DEHP, respectively. Estimated daily intake for DEP and DiBP were lower than those of other studies but the value for DEHP was higher than that of other study.

• 한국환경농학회지
• /
• 제32권4호
• /
• pp.315-322
• /
• 2013

BACKGROUND: This study was performed for the identification and quantification of glucosinolate (GSL) contents in seven varieties of rapeseed (Brassica napus L.) sprouts cultivated under dark and light conditions. METHODS AND RESULTS: Crude glucosinolates (GSLs) were desulfated by treating with aryl sulfatase and purified using diethylaminoethyl sepharose (DEAE) anion exchange column. Individual GSLs were quantified using high-performance liquid chromatography (HPLC) with electrospray ionization-tandem mass spectrometry (ESI-MS/MS). Eleven GSLs including six aliphatic (progoitrin, sinigrin, glucoalyssin, gluconapoleiferin, gluconapin, and glucobrassicanapin), four indolyl (4-hydroxyglucobrassicin, glucobrassicin, 4-methoxyglucobrassicin, and neoglucobrassicin) and one aromatic (gluconasturtiin) were identified based on the fragmentation patterns of MS spectrum. Aliphatic GSLs were noted as the predominant group with average 85.2% of the total contents. The most abundant GSLs were progoitrin which was ranged at $8.14-118.68{\mu}mol/g$ dry weight (DW). The highest total GSL amounts were documented in 'Hanra' ($146.02{\mu}mol/g$ DW) under light condition and 'Mokpo No. 68' ($86.67{\mu}mol/g$ DW) in dark condition, whereas the lowest was in 'Tamra' (30.13 and $14.50{\mu}mol/g$ DW) in both conditions. The sum of aliphatic GSLs attributed > 80% in all varieties, except 'Tamra' (67.7% and 64.9% in dark and light conditions, respectively) in the total GSL accumulation. Indolyl GSLs were ranged $2.41-15.73{\mu}mol/g$ DW, accounted 2.78-33.6% of the total GSLs in rapeseed varieties. CONCLUSION(S): These results provide valuable information regarding potential beneficial GSL contents individually. This study attempts to contribute to knowledge of the nutritional properties of the different varieties of rapeseed plants. These results may be useful for the evaluation of dietary information.

• Journal of Pharmaceutical Investigation
• /
• 제39권2호
• /
• pp.133-139
• /
• 2009

The purpose of the present study was to evaluate the bioequivalence of two pioglitazone HCl tablets, $Actos^{TM}$, tablets (Lilly Korea. Ltd., Korea) as a reference drug and $Piros^{TM}$, tablets (Reyon Pharm. Co., Ltd., Korea) as test drug, according to the guideline of Korea Food and Drug Administration (KFDA). Twenty-four healthy male Korean volunteers received one tablet containing pioglitazone HCl 15 mg in a $2{\times}2$ crossover study. There was a one-week washout period between the doses. Plasma concentrations of pioglitazone were monitored for over a period of 36 hr after administration by using a high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS). The area under the plasma concentration-time curve from time zero to 36 hr ($AUC_{0-36hr}$), maximum plasma drug concentration ($C_{max}$) and time to reach $C_{max}$ ($T_{max}$) were complied from the plasma concentration-time data. Analysis of variance (ANOVA) test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_{0-36hr}$ and $C_{max}$. The 90% confidence intervals of the $AUC_{0-36hr}$ ratio and the $C_{max}$ ratio for $Piros^{TM}$/$Actos^{TM}$. were log 0.8753-log 1.1286 and log 0.8669-log 1.1734, respectively. These values were within the acceptable bioequivalence intervals of log 0.80-log 1.25, recommended by KFDA. In all of these results, we concluded that the $Piros^{TM}$. tablet was bioequivalent to the $Actos^{TM}$. tablet, based on the rate and extent of absorption.

• 생물정신의학
• /
• 제18권2호
• /
• pp.95-100
• /
• 2011

Objectives To evaluate the drug interactions between aripiprazole and haloperidol, authors investigated plasma concentrations of those drugs by genotypes. Method Fifty six patients with a confirmed Diagnostic and Statistical Manual of Mental Disorders 4th edition diagnosis of schizophrenia were enrolled in this eight-week, double blind, placebo-controlled study. Twenty-eight patients received adjunctive aripiprazole treatment and twenty-eight patients received placebo while being maintained on haloperidol treatment. Aripiprazole was dosed at 15 mg/day for the first 4 weeks, and then 30 mg for the next 4 weeks. The haloperidol dose remained fixed throughout the study. Plasma concentrations of haloperidol and aripiprazole were measured by high-performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) at baseline, week 1, 2, 4 and 8. $^*1$, $^*5$, and $^*10$ B alleles of CYP2D6 and $^*1$ and $^*3$ alleles of CYP3A5 were determined. The Student's T-test, Pearson's Chi-square test, Wilcoxon Rank Sum test and Logistic Regression analysis were used for data analysis. All tests were two-tailed and significance was defined as an alpha < 0.05. Results In the frequency of CYP2D6 genotype, $^*1/^*10$ B type was most frequent (36.5%) and $^*1/^*1$ (30.8%), $^*10B/^*10B$ (17.3%) types followed. In the frequency of CYP3A5 genotype, $^*3/^*3$ type was found in 63.5% of subjects, and $^*1/^*3$ type and $^*1/^*1$ were 30.8% and 5.8% respectively. The plasma levels of haloperidol and its metabolites did not demonstrate significant time effects and time-group interactions after adjunctive treatment of aripiprazole. The genotypes of CYP2D6 and 3A5 did not affect the plasma concentration of haloperidol in this trial. No serious adverse event was found after adding aripiprazole to haloperidol. Conclusion No significant drug interaction was found between haloperidol and aripiprazole. Genotypes of CYP2D6 and 3A5 did not affect the concentration of haloperidol after adding aripiprazole.

• Journal of Pharmaceutical Investigation
• /
• 제40권2호
• /
• pp.125-131
• /
• 2010

A bioequivalence study of LANIDIEM$^{(R)}$ tablet 4 mg (Samil. Co., Ltd.) to Vaxar$^{(R)}$ tablet 4 mg (GlaxoSmithKline Co., Ltd.) was conducted according to the guidelines of Korea Food and Drug Administration (KFDA). Forty healthy male Korean volunteers were enrolled in the study and thirty six volunteers completed the study according to the protocol. Thirty six volunteers received each medicine at the lacidipine dose of 4 mg in a $2{\times}2$ crossover study. There was one week wash-out period between the doses. Plasma concentrations of lacidipine were monitored by a high performance liquid chromatography - tandem mass spectrometry (LC-MS/MS) for over a period of 24 hours after drug administration. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 24 hr) was calculated by the linear trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were compiled from the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for LANIDIEM$^{(R)}$/Vaxar$^{(R)}$ were log 0.8102~log 1.0417 and log 0.8493~log 1.1439, respectively. These values were within the acceptable bioequivalence intervals of log 0.80~log 1.25. Thus, our study demonstrated the bioequivalence of LANIDIEM$^{(R)}$ tablet 4 mg and Vaxar$^{(R)}$ tablet 4 mg with respect to the rate and extent of absorption.

• 한국식품위생안전성학회지
• /
• 제32권5호
• /
• pp.389-395
• /
• 2017

루이보스티에서 5종의 phenolic acid (gallic acid, chlorogenic acid, caffeic acid, p-coumaric acid, trans-ferulic acid)와 9종의 flavonoid (procyanidin b1, aspalathin, rutin, vitexin, hyperoside, isoquercitrin, luteolin, quercetin, chrysoeriol)를 UPLC-MSMS를 이용하여 동시 분석하였다. 14종 페놀릭류를 동시 분석하기 위하여 기기조건과 유효성을 검증하였고 확립된 분석방법을 이용하여 시중에 유통중인 루이보스티 30건을 채취하여 페놀릭류를 분석하였다. 루이보스티 1 g 혹은 1티백에 뜨거운 물 100 mL을 가하여 3분, 6분, 30분이 경과 후 그리고 차가운 물 ($25-30^{\circ}C$)에 30분 우려낸 루이보스티의 페놀릭류 함량을 구하였다. 루이보스티에서 전체 실험대상 페놀릭류 중 rutin과 aspalathin이 가장 많이 추출되어 나왔으며 각각 물질의 함량은 제품별로 달랐다. 페놀릭류 성분의 추출효율은 14종 페놀릭류의 총합 기준으로 뜨거운 물 30분 > 6분 > 3분 > 차가운 물 30분 순으로 높았다.